Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MANISHA JHAMB

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1144457490
CMS profile
709670
Location
PITTSBURGH, PA

General Payments · PY2018–2024

$42,188.09

  • Reported across 107 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$16,474.70

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $10,182.22 14
Lilly USA, LLC $5,570.00 5
Relypsa, Inc. $335.59 3
Retrophin, Inc. $281.44 5
Janssen Pharmaceuticals, Inc $105.45 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $309.72 3
PY2019 $407.82 6
PY2020 $171.73 2
PY2021 $935.03 8
PY2022 $7,145.90 17
PY2023 $16,743.19 43
PY2024 $16,474.70 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $146.81 02/04/2024 Food and Beverage Undisputed 01/23/2026 1117890373 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $280.12 02/04/2024 Travel and Lodging Undisputed 01/23/2026 1117890381 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $914.14 02/07/2024 Travel and Lodging Undisputed 01/23/2026 1117890383 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.45 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117890359 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.45 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117890361 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $44.86 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117890365 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $44.86 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117890367 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $112.18 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117890369 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $270.07 02/12/2024 Travel and Lodging Undisputed 01/23/2026 1117890379 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $168.64 02/16/2024 Travel and Lodging Undisputed 01/23/2026 1117890375 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $178.64 02/16/2024 Travel and Lodging Undisputed 01/23/2026 1117890377 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 03/04/2024 Food and Beverage Undisputed 01/23/2026 1117890363 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 03/04/2024 Travel and Lodging Undisputed 01/23/2026 1117890371 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7,800.00 03/04/2024 Consulting Fee Undisputed 01/23/2026 1117890385 CMS
Janssen Pharmaceuticals, Inc $105.45 06/26/2024 Food and Beverage Undisputed 01/23/2026 1078159229 CMS
Lilly USA, LLC $5,415.00 02/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135141663 CMS
Lilly USA, LLC $25.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 1135104669 CMS
Lilly USA, LLC $40.00 03/20/2024 Travel and Lodging Undisputed 01/23/2026 1135146053 CMS
Lilly USA, LLC $50.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 1135163017 CMS
Lilly USA, LLC $40.00 03/20/2024 Travel and Lodging Undisputed 01/23/2026 1135163019 CMS
Travere Therapeutics, Inc. $15.87 06/27/2024 Food and Beverage Undisputed 01/23/2026 1149922199 CMS
Travere Therapeutics, Inc. $99.60 06/27/2024 Food and Beverage Undisputed 01/23/2026 1149922207 CMS
Travere Therapeutics, Inc. $2.52 08/02/2024 Food and Beverage Undisputed 01/23/2026 1149922196 CMS
Travere Therapeutics, Inc. $114.50 10/15/2024 Food and Beverage Undisputed 01/23/2026 1149922211 CMS
Travere Therapeutics, Inc. $48.95 10/26/2024 Food and Beverage Undisputed 01/23/2026 1149922203 CMS
Vifor Pharma, Inc. $127.58 04/20/2024 Food and Beverage Undisputed 01/23/2026 1124041934 CMS
Vifor Pharma, Inc. $101.01 07/25/2024 Food and Beverage Undisputed 01/23/2026 1124055043 CMS
Vifor Pharma, Inc. $107.00 11/07/2024 Food and Beverage Undisputed 01/23/2026 1124066282 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.